Recent studies, such as that by Wang L. et al., have uncovered new facets of TGF-β1's role in ITP, particularly in the context of TPO receptor agonists (TPO-RAs). This evidence concerns the gene TGFB1 and autoimmune thrombocytopenic purpura.